DSpace
 

KNUSTSpace >
Theses / Dissertations >
College of Health Sciences >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/11947

Title: Comparison of Two Assays for Molecular Determination of Rifampin Resistance in Clinical Samples from Patients with Buruli Ulcer Disease
Authors: Phillips, Richard O.
Jansson, Moritz
Beissner, Marcus
Badziklou, Kossi
Piten, Ebekalisai
et. al
Issue Date: 29-Jan-2014
Publisher: Journal of Clinical Microbiology
Citation: Journal of Clinical Microbiology Volume 52 p. 1246–1249
Abstract: Buruli ulcer disease (BUD), caused by Mycobacterium ulcerans, involves the skin, subcutaneous fatty tissue, and bones and predominantly affects children 15 years of age. If left untreated, contractures may cause severe functional limitation. Standardized antimycobacterial treatment consists of rifampin (RMP) and streptomycin administered for 8 weeks. An oral regimen combiningRMPand clarithromycin is currently under clinical evaluation (1–3). Notwithstanding the efficiency of chemotherapy, treatment failures and various types of secondary lesions have been reported, suggesting the need for customized clinical management strategies (4–6).
Description: An article published by Journal of Clinical Microbiology and available doi.org/10.1128 /JCM.03119-13.
URI: http://hdl.handle.net/123456789/11947
Appears in Collections:College of Health Sciences

Files in This Item:

File Description SizeFormat
Comparison of Two Assays for Molecular Determination of Rifampin Resistance in Clinical Samples from Patients with Buruli Ulcer Disease.pdf128.96 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback